Fri, Jan 30, 2015, 1:58 AM EST - U.S. Markets open in 7 hrs 32 mins

Recent

% | $
Quotes you view appear here for quick access.

XOMA Corporation Message Board

supernova60609 9 posts  |  Last Activity: Jan 24, 2015 5:36 PM Member since: Jan 28, 2000
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • supernova60609 supernova60609 Jan 24, 2015 5:36 PM Flag

    So Jenny why don't you contact the FDA on behalf of XOMA and explain to them that a Phase 3 study is not needed. After all the Phase 2 results were conclusive were they not? The answer is simple....you would sound like a buffoon who knows nothing about medical research and statistical analysis.

    So I'm going to do you a favor. Here is the name of an excellent book you should read "Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice, 2nd Edition." Take some time to read it over. It will serve you well when looking at research publications and clinical trial results. Remember what Benjamin D'sraeli famously said. "There are three types of lies....lies, damn lies and statistics."

    Jenny I wish you the best of luck in your investment career....sound knowledge will empower you and provide a strong foundation for your future investments.

    P.S. I hope you are right about the Phase 3 studies. But hope is not the basis for successful investing.

    Super.

  • supernova60609 supernova60609 Jan 23, 2015 2:06 PM Flag

    The combination of these two antihypertensives is not particularly interesting. There are many competing dual antihypertensive pills on the market. Think of this new combination pill as a variation of a common mouse trap...of some value but not much. Is there money to be made? Sure. A lot of money? I doubt it. And XOMA will get a small percentage of not too much money starting in 2016.....maybe. The reaction of the share price of XOMA seems to reflect this. A big yawn...

  • supernova60609 supernova60609 Jan 23, 2015 1:58 PM Flag

    Jenny....you need to remember that XOMA had positive Phase 2 results with E5 20+ years ago and it failed in Phase 3 trials. And Jenny....you need to remember that XOMA has positive Phase 2 results with Neuprex in meningococcemia and it failed in Phase 3 trials too. So you see Jenny, success in a phase 2 trial on a statistical basis in general and for XOMA in particular rarely goes on to Phase 3 success. Ipso Facto Jenny... Good luck.

  • Reply to

    Just the facts

    by supernova60609 Jan 7, 2015 12:13 PM
    supernova60609 supernova60609 Jan 22, 2015 9:59 AM Flag

    Hey Chinaman.....still waiting to learn my lesson. Ain't it hard when the student becomes the teacher.
    Look...I understand your hope and pain. But ipso facto my friend... Maybe I'll be proved wrong but 30 years of failures on XOMA's part suggets otherwise. Yes....I know...this time it will be different. Blah, blah, blah.....

  • Reply to

    Just the facts

    by supernova60609 Jan 7, 2015 12:13 PM
    supernova60609 supernova60609 Jan 14, 2015 10:33 AM Flag

    I'm watching.......

  • supernova60609 by supernova60609 Jan 7, 2015 12:13 PM Flag

    #1 Results from Bechet's study are now 6 months over due and counting.
    #2 The Bakers have unloaded approximately 25% of their holding; slowly so as not to cause a panic.
    #3 Further dilution occurred two months ago suggesting the management felt $5.00/share was a good price to #$%$ a bit more money. If management felt great news was just around the corner why not wait and dilute at say $10 - $15/share. Why? Because greeat news is very unlikely.

    Just the facts.

  • Reply to

    BB's

    by onyxpig Jan 7, 2015 7:30 AM
    supernova60609 supernova60609 Jan 7, 2015 12:05 PM Flag

    The BBs wouldn't be selling ANY shares if they thought a substantial return was just around the corner. They're backing out slowly so as to avoid a panic and a complete rout in their XOMA investment.

  • Reply to

    Baker Bross sold for 11mUSD

    by pmalota Dec 6, 2014 10:31 AM
    supernova60609 supernova60609 Dec 11, 2014 8:49 PM Flag

    Dr. Moors is sticking his head out.....watch his head get severed from his torso when the Phase III results finally come out.

  • Reply to

    Baker Bross sold for 11mUSD

    by pmalota Dec 6, 2014 10:31 AM
    supernova60609 supernova60609 Dec 11, 2014 8:46 PM Flag

    Phase III results delayed by over 6 months. Major holder slowly unloading shares (Bakers). Second dilutional offering in 14 months. Last time they diluted was a month before a negative announcement. You're delusional if you can spin this in any positive way. Prepare yourselves again for a big disappointment followed by the management spin that their next drug shows great promise and there is enough cash available to see it through phase 3 studies. Just look back on the press releases over the past 5-10 years. It's the same pattern year after year.

XOMA
3.67-0.050(-1.34%)Jan 29 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Core Laboratories NV
NYSEThu, Jan 29, 2015 4:00 PM EST
Facebook, Inc.
NASDAQThu, Jan 29, 2015 4:00 PM EST